Lithium treatment and GKS3 suppression could lead to kidney failure
Researchers have warned that certain psychiatric medications and treatments for bipolar disease could lead to the development of kidney failure...
List view / Grid view
Researchers have warned that certain psychiatric medications and treatments for bipolar disease could lead to the development of kidney failure...
ProCellics™ software is available with ProCellics™ GMP bioprocess in-line analyser. ProCellics™ software has been specifically developed to address bioprocess monitoring needs...
Researchers have developed an AI system that could cut the time it takes for X-rays to be examined, analysed and processed...
NIR-GECO1 could help the development of effective treatments for pressing health conditions, including neurodegenerative diseases
A study has found that long term aspirin use increases patients' risk of major bleeding events by 43 percent, with 1 in 200 having a major bleed...
Results did not confirm the clinical benefit of Lartruvo in combination with doxorubicin compared to doxorubicin alone…
A paediatric treatment for 2 to 5 year olds has been approved by the European Commission to treat children with the most common form of cystic fibrosis...
A blood test could identify whether a newly transplanted lung is being rejected by a patient, despite there being no outward features...
A combination of AmBisome monotherapy and miltefosine could be beneficial when treating a coinfection of HIV and visceral leishmaniasis...
Researchers have developed an enhanced NMR method that could determine the structures of complex molecules much quicker than before...
Of the 21 drugs designed for delivery directly to the female genital tract, only four have a cost-effective, generic equivalent...
Software that can bypass current intellectual property and design medication with the same function as top drugs could help pharma companies...
Erleada (apalutamide) has been approved for non-metastatic castration-resistant prostate cancer patients who are at high risk of developing metastatic disease
A Phase I/IIa study has shown that arfolitixorin along with either irinotecan or oxaliplatin could shrink the size of tumours in colorectal cancer patients...
The Almac Group, a CDMO serving the pharmaceutical and biotech sectors globally, is expanding its Edinburgh Technopole facility to allow scale-up of its personalised cancer vaccine activities...